Scholar Rock Holding Corp.
(NASDAQ : SRRK)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Interested in Binary Options?
We'll teach you the best ways to trade binaries.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
MRNAModerna, Inc. -3.01%152.520.0%$4782.73m
NVAXNovavax, Inc. -2.25%126.2592.9%$675.98m
BNTXBioNTech SE 1.11%120.000.0%$672.24m
AMGNAmgen, Inc. 1.01%229.211.3%$578.56m
GILDGilead Sciences, Inc. 1.15%61.561.0%$506.97m
BIIBBiogen, Inc. 0.73%245.871.7%$496.02m
REGNRegeneron Pharmaceuticals, Inc. -1.28%492.452.7%$472.10m
VRTXVertex Pharmaceuticals, Inc. 0.64%228.321.9%$455.95m
ILMNIllumina, Inc. 1.35%350.663.5%$426.07m
EXASEXACT Sciences Corp. 1.68%132.8719.6%$207.83m
SGENSeagen Inc. -0.52%179.235.8%$156.07m
BGNEBeiGene Ltd. 0.71%222.881.4%$141.27m
CRSPCRISPR Therapeutics AG 5.04%147.540.6%$137.84m
TXG10X Genomics, Inc. 2.63%149.040.0%$136.40m
SRNESorrento Therapeutics, Inc. 0.00%7.971.4%$136.15m

Company Profile

Scholar Rock Holding Corp. is a biopharmaceutical company. It engages in the development and discovery of innovative medicines. The company offers proprietary platform which designed to discover and develop monoclonal antibodies that have a high degree of specificity to achieve selective modulation of growth factor signaling. Its product candidate includes SRK-015 and SRK-181. The company was founded by Timothy A. Springer and Leonard I. Zon in October 2012 and is headquartered in Cambridge, MA.